~ Buy the SODIUM POLYSTYRENE SULFONATE Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

SODIUM POLYSTYRENE SULFONATE Drug Patent Profile

When do Sodium Polystyrene Sulfonate patents expire, and when can generic versions of Sodium Polystyrene Sulfonate launch?

Sodium Polystyrene Sulfonate is a drug marketed by Belcher, Chartwell Rx, Citrusphrma, Cmp Pharma Inc, Epic Pharma Llc, Nuvo Pharms Inc, Pai Holdings Pharm, Upsher Smith Labs, Ani Pharms, Hikma, Morton Grove, and Roxane. and is included in twelve NDAs.

The generic ingredient in SODIUM POLYSTYRENE SULFONATE is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Sodium Polystyrene Sulfonate

A generic version of SODIUM POLYSTYRENE SULFONATE was approved as sodium polystyrene sulfonate by CMP PHARMA INC on January 19^th, 1989.

Summary for SODIUM POLYSTYRENE SULFONATE

US Patents:	0
Applicants:	12
NDAs:	12
Finished Product Suppliers / Packagers:	9
Raw Ingredient (Bulk) Api Vendors:	56
Clinical Trials:	7
Drug Prices:	Drug price information for SODIUM POLYSTYRENE SULFONATE
DailyMed Link:	SODIUM POLYSTYRENE SULFONATE at DailyMed

See drug prices for SODIUM POLYSTYRENE SULFONATE

Recent Clinical Trials for SODIUM POLYSTYRENE SULFONATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of California, Irvine	Phase 4
Tris Pharma, Inc.	Phase 4
Weill Medical College of Cornell University	Phase 4

See all SODIUM POLYSTYRENE SULFONATE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for SODIUM POLYSTYRENE SULFONATE

V03AE	Drugs for treatment of hyperkalemia and hyperphosphatemia
V03A	ALL OTHER THERAPEUTIC PRODUCTS
V03	ALL OTHER THERAPEUTIC PRODUCTS
V	Various

US Patents and Regulatory Information for SODIUM POLYSTYRENE SULFONATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Belcher	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER;ORAL, RECTAL	205727-001	Feb 23, 2016	AA	RX	No	No
Nuvo Pharms Inc	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER;ORAL, RECTAL	204071-001	Nov 28, 2014	AA	RX	No	No
Cmp Pharma Inc	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER;ORAL, RECTAL	089910-001	Jan 19, 1989	AA	RX	No	No
Morton Grove	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	SUSPENSION;ORAL, RECTAL	088717-001	Sep 11, 1984		DISCN	No	No
Pai Holdings Pharm	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER;ORAL, RECTAL	088786-001	Sep 11, 1984		DISCN	Yes	No
Chartwell Rx	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER;ORAL, RECTAL	206815-001	Feb 18, 2016	AA	RX	No	No
Citrusphrma	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER;ORAL, RECTAL	040909-001	Dec 3, 2008		DISCN	No	No